{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-008981","form_type":"8-K","ticker":"WINT","cik":"0000946486","company_name":"WINDTREE THERAPEUTICS INC /DE/","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.906240+00:00","generated_at":"2026-05-24T07:49:17.243964+00:00","sec_items":["1.01","2.03","7.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Windtree raises $250K via secured notes, licenses Phexxi supply rights, regains Nasdaq compliance","bullets":["Issued $312,500 principal in senior secured notes at 10% interest, due March 2026, with 20% OID; net proceeds $250,000.","Entered license and supply agreement with Evofem to manufacture and supply Phexxi outside the U.S. for an initial three-year term.","Regained compliance with Nasdaq minimum bid price rule (closing bid >$1.00 since Feb 21, 2025); subject to panel monitor until March 20, 2026.","Notes secured by first-priority lien on all assets; mandatory redemption of 30% of equity line proceeds if equity line is used."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-008981","json":"https://secwatch.observer/filing/0001437749-25-008981.json","markdown":"https://secwatch.observer/filing/0001437749-25-008981.md","text":"https://secwatch.observer/filing/0001437749-25-008981.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/0001437749-25-008981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946486/000143774925008981/wint20250323_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T07:49:17.243964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}